Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 3
1977 5
1978 10
1979 6
1980 3
1981 14
1982 6
1983 7
1984 18
1985 18
1986 11
1987 13
1988 11
1989 10
1990 15
1991 9
1992 12
1993 2
1994 8
1995 8
1996 6
1997 5
1998 3
1999 3
2000 4
2001 4
2002 2
2003 9
2004 8
2005 15
2006 12
2007 10
2008 16
2009 7
2010 11
2011 13
2012 13
2013 17
2014 30
2015 25
2016 36
2017 35
2018 35
2019 29
2020 28
2021 26
2022 27
2023 19
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

571 results

Results by year

Filters applied: . Clear all
Page 1
Occupational Therapy for Adults With Cancer: Why It Matters.
Pergolotti M, Williams GR, Campbell C, Munoz LA, Muss HB. Pergolotti M, et al. Among authors: muss hb. Oncologist. 2016 Mar;21(3):314-9. doi: 10.1634/theoncologist.2015-0335. Epub 2016 Feb 10. Oncologist. 2016. PMID: 26865588 Free PMC article. Review.
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.
Demaria M, O'Leary MN, Chang J, Shao L, Liu S, Alimirah F, Koenig K, Le C, Mitin N, Deal AM, Alston S, Academia EC, Kilmarx S, Valdovinos A, Wang B, de Bruin A, Kennedy BK, Melov S, Zhou D, Sharpless NE, Muss H, Campisi J. Demaria M, et al. Among authors: muss h. Cancer Discov. 2017 Feb;7(2):165-176. doi: 10.1158/2159-8290.CD-16-0241. Epub 2016 Dec 15. Cancer Discov. 2017. PMID: 27979832 Free PMC article.
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L. Citron ML, et al. Among authors: muss hb. J Clin Oncol. 2003 Apr 15;21(8):1431-9. doi: 10.1200/JCO.2003.09.081. Epub 2003 Feb 13. J Clin Oncol. 2003. PMID: 12668651 Clinical Trial.
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Hughes KS, et al. Among authors: muss hb. J Clin Oncol. 2013 Jul 1;31(19):2382-7. doi: 10.1200/JCO.2012.45.2615. Epub 2013 May 20. J Clin Oncol. 2013. PMID: 23690420 Free PMC article. Clinical Trial.
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
Jones S, Holmes FA, O'Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer WG, Asmar L, Mackey D, Riedel S, Muss H, Savin MA. Jones S, et al. Among authors: muss h. J Clin Oncol. 2009 Mar 10;27(8):1177-83. doi: 10.1200/JCO.2008.18.4028. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204201 Clinical Trial.
Measuring Biologic Resilience in Older Cancer Survivors.
Sedrak MS, Gilmore NJ, Carroll JE, Muss HB, Cohen HJ, Dale W. Sedrak MS, et al. Among authors: muss hb. J Clin Oncol. 2021 Jul 1;39(19):2079-2089. doi: 10.1200/JCO.21.00245. Epub 2021 May 27. J Clin Oncol. 2021. PMID: 34043454 Free PMC article. Review. No abstract available.
Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, van Deventer HW, Dees EC, Serody JS. Vincent BG, et al. Among authors: muss hb. J Immunol. 2023 Jul 15;211(2):219-228. doi: 10.4049/jimmunol.2300077. J Immunol. 2023. PMID: 37204246 Free PMC article. Clinical Trial.
571 results